Director/PDMR Shareholding

RNS Number : 9956P

GlaxoSmithKline PLC

11 October 2011

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 11 October 2011 of an increase in their notional interests in Ordinary shares at a price of 1365 pence per Ordinary share and ADRs at a price of $42.37 per ADR following the notional re-investment of the dividend paid to shareholders on 6 October 2011.

	Ordinary shares	ADRs
Mr A P Witty	16,333.149
Dr M M Slaoui		4,489.084
Mr S M Bicknell	1,452.966
Mr J M Clarke	4,066.730
Mrs D P Connelly		2,641.762
Mr M Dunoyer	1,911.604
Mr E J Gray	3,069.056
Mr S A Hussain	4,012.727
Mr W C Louv		1,354.326
Dr D Pulman		2,029.879
Mr D S Redfern	1,871.948
Mr J R Stéphenne	2,352.046
Ms C Thomas	2,698.368
Mr P C Thomson	217.896
Mr D E Troy		2,679.555
Dr P J T Vallance	2,651.523
Ms E Walmsley	1,577.548
Mrs V A Whyte	217.896

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

11 October 2011

 

END

 

 

RDSEFLFFFBFEFBL